USPTO trademark

IMMUNOVEDA

RegisteredUSPTOWord and designClass 42

"IMMUNOVEDA" is a word and design mark owned by Genesis Drug, Discovery & Development, LLC, filed at the USPTO on June 1, 2023. It is registered and covers class 42 (Computer and Scientific Services).

Get this data via the API
Official USPTO record
IMMUNOVEDA trademark as filed
As filed with the USPTO
Status
Registered
Since June 18, 2024
Filed
June 1, 2023
Registered
June 18, 2024
Expires
Not recorded
Application no.
98023632
Registration no.
7420266
Office
USPTO
United States Patent and Trademark Office
Mark type
Word and design
1 class
Ownership

Who owns IMMUNOVEDA

The owner and representative on file with the office.

Owner

Genesis Drug, Discovery & Development, LLC

Hamilton, United States

Representative

Christina E. Brule

Heslin Rothenberg Farley & Mesiti P.C.

Goods and services

What the mark covers

The products and services IMMUNOVEDA is filed for, grouped by Nice class.

  • Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Medical research services in the field of cancer; Medical and scientific research in the field of cancer treatment and diagnosis; Providing laboratory research services in the field of gene expression, namely, cancer biology

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of registration confirmation emailed
  2. Registered-principal register
  3. Official gazette publication confirmation e-mailed
  4. Published for opposition
  5. Notification of notice of publication e-mailed
  6. Approved for pub - principal register
  7. Assigned to examiner
  8. Teas withdrawal of attorney received-firm retains
  9. Teas change of correspondence received
  10. Attorney/dom.rep.revoked and/or appointed

4 earlier steps on the official record.

FAQ

About IMMUNOVEDA

Who owns the trademark "IMMUNOVEDA"?

The USPTO trademark "IMMUNOVEDA" (application 98023632) is owned by Genesis Drug, Discovery & Development, LLC.

What is the status of "IMMUNOVEDA"?

Its status at the USPTO is: registered.

When was "IMMUNOVEDA" registered?

It was registered on June 18, 2024.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull IMMUNOVEDA and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2bc8-0bd9-76ec-9dd6-0b74bce0ac09
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2bc8-0bd9-76ec-9dd6-0b74bce0ac09",
  "object": "trademark",
  "mark_text": "IMMUNOVEDA",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "98023632",
  "filing_date": "2023-06-01",
  "nice_classes": [
    42
  ],
  "owners": [
    {
      "name": "Genesis Drug, Discovery & Development, LLC",
      "entity_id": null
    }
  ]
}